Lie Ming Ding

Wuhan Healthgen Biotechnology Corp. engages in the research and development in molecular pharmaceutical. Its products include recombinant human serum albumin, recombinant growth products, and proteins for cosmetics ingredients. The company was founded by Dai Chang Yang, Cai Yuan Bai, and Zhong Qiang Yuan on November 16, 2006 and is headquartered in Wuhan, China.

Wuhan Healthgen Biotechnology Corp. engages in the research and development in molecular pharmaceutical. Its products include recombinant human serum albumin, recombinant growth products, and proteins for cosmetics ingredients. The company was founded by Dai Chang Yang, Cai Yuan Bai, and Zhong Qiang Yuan on November 16, 2006 and is headquartered in Wuhan, China.

Wuhan Healthgen Biotechnology Corp. engages in the research and development in molecular pharmaceutical. Its products include recombinant human serum albumin, recombinant growth products, and proteins for cosmetics ingredients. The company was founded by Dai Chang Yang, Cai Yuan Bai, and Zhong Qiang Yuan on November 16, 2006 and is headquartered in Wuhan, China.

Wuhan Healthgen Biotechnology Corp. engages in the research and development in molecular pharmaceutical. Its products include recombinant human serum albumin, recombinant growth products, and proteins for cosmetics ingredients. The company was founded by Dai Chang Yang, Cai Yuan Bai, and Zhong Qiang Yuan on November 16, 2006 and is headquartered in Wuhan, China.

Wuhan Healthgen Biotechnology Corp. engages in the research and development in molecular pharmaceutical. Its products include recombinant human serum albumin, recombinant growth products, and proteins for cosmetics ingredients. The company was founded by Dai Chang Yang, Cai Yuan Bai, and Zhong Qiang Yuan on November 16, 2006 and is headquartered in Wuhan, China.

Wuhan Healthgen Biotechnology Corp. engages in the research and development in molecular pharmaceutical. Its products include recombinant human serum albumin, recombinant growth products, and proteins for cosmetics ingredients. The company was founded by Dai Chang Yang, Cai Yuan Bai, and Zhong Qiang Yuan on November 16, 2006 and is headquartered in Wuhan, China.

Wuhan Healthgen Biotechnology Corp. engages in the research and development in molecular pharmaceutical. Its products include recombinant human serum albumin, recombinant growth products, and proteins for cosmetics ingredients. The company was founded by Dai Chang Yang, Cai Yuan Bai, and Zhong Qiang Yuan on November 16, 2006 and is headquartered in Wuhan, China.

Wuhan Healthgen Biotechnology Corp. engages in the research and development in molecular pharmaceutical. Its products include recombinant human serum albumin, recombinant growth products, and proteins for cosmetics ingredients. The company was founded by Dai Chang Yang, Cai Yuan Bai, and Zhong Qiang Yuan on November 16, 2006 and is headquartered in Wuhan, China.

Wuhan Healthgen Biotechnology Corp. engages in the research and development in molecular pharmaceutical. Its products include recombinant human serum albumin, recombinant growth products, and proteins for cosmetics ingredients. The company was founded by Dai Chang Yang, Cai Yuan Bai, and Zhong Qiang Yuan on November 16, 2006 and is headquartered in Wuhan, China.

Wuhan Healthgen Biotechnology Corp. engages in the research and development in molecular pharmaceutical. Its products include recombinant human serum albumin, recombinant growth products, and proteins for cosmetics ingredients. The company was founded by Dai Chang Yang, Cai Yuan Bai, and Zhong Qiang Yuan on November 16, 2006 and is headquartered in Wuhan, China.

Wuhan Healthgen Biotechnology Corp. engages in the research and development in molecular pharmaceutical. Its products include recombinant human serum albumin, recombinant growth products, and proteins for cosmetics ingredients. The company was founded by Dai Chang Yang, Cai Yuan Bai, and Zhong Qiang Yuan on November 16, 2006 and is headquartered in Wuhan, China.

Wuhan Healthgen Biotechnology Corp. engages in the research and development in molecular pharmaceutical. Its products include recombinant human serum albumin, recombinant growth products, and proteins for cosmetics ingredients. The company was founded by Dai Chang Yang, Cai Yuan Bai, and Zhong Qiang Yuan on November 16, 2006 and is headquartered in Wuhan, China.

Wuhan Healthgen Biotechnology Corp. engages in the research and development in molecular pharmaceutical. Its products include recombinant human serum albumin, recombinant growth products, and proteins for cosmetics ingredients. The company was founded by Dai Chang Yang, Cai Yuan Bai, and Zhong Qiang Yuan on November 16, 2006 and is headquartered in Wuhan, China.

Wuhan Healthgen Biotechnology Corp. engages in the research and development in molecular pharmaceutical. Its products include recombinant human serum albumin, recombinant growth products, and proteins for cosmetics ingredients. The company was founded by Dai Chang Yang, Cai Yuan Bai, and Zhong Qiang Yuan on November 16, 2006 and is headquartered in Wuhan, China.

Ningbo Kaiming Venture Technology Co., Ltd. engages in software development. The company was founded on June 4, 2020 and is headquartered in Ningbo, China.

Zhejiang Betta Pharmaceuticals Co., Ltd. engages in the research and development of anti-cancer drugs. The company was founded on November 22, 2013 and is headquartered in Hangzhou, China.

Wuhan Healthgen Biotechnology Corp. engages in the research and development in molecular pharmaceutical. Its products include recombinant human serum albumin, recombinant growth products, and proteins for cosmetics ingredients. The company was founded by Dai Chang Yang, Cai Yuan Bai, and Zhong Qiang Yuan on November 16, 2006 and is headquartered in Wuhan, China.